search
Back to results

Effects of Long Biliopancreatic Limb vs. Long Alimentary Limb in Superobesity, a Randomized Study

Primary Purpose

Morbid Obesity, Weight Loss

Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
gastric bypass
Sponsored by
Aleris Obesity
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Morbid Obesity focused on measuring gastric bypass, morbid obesity, gut function, weight loss

Eligibility Criteria

18 Years - 55 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • BMI 50-65
  • Age 18-55
  • Conservative attempts at weight reduction failed

Exclusion Criteria:

  • Inability to speak and understand the Swedish language
  • Residence outside the county of Skåne
  • Psychotic disease
  • Inflammatory bowel disease

Sites / Locations

  • Aleris Obesity Skåne

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

standard length bp limb, long alimentary limb

Long BP limb

Arm Description

our normal way of doing a gastric bypass 60 cm BP limb

200 cm BP limb

Outcomes

Primary Outcome Measures

body weight reduction
absolute BW reduction, percentage of patients reaching BMI below 30,

Secondary Outcome Measures

gastrointestinal function
SF-36, Op-9, GSRS and TFEQ are used in patient assessed variables

Full Information

First Posted
January 18, 2012
Last Updated
February 24, 2020
Sponsor
Aleris Obesity
search

1. Study Identification

Unique Protocol Identification Number
NCT01514799
Brief Title
Effects of Long Biliopancreatic Limb vs. Long Alimentary Limb in Superobesity, a Randomized Study
Official Title
Randomized Study Comparing the Effects of Gastric Bypass Using a Long BP-limb vs. a Long Alimentary Limb in Morbid Obesity
Study Type
Interventional

2. Study Status

Record Verification Date
February 2020
Overall Recruitment Status
Completed
Study Start Date
August 29, 2011 (Actual)
Primary Completion Date
November 20, 2015 (Actual)
Study Completion Date
February 1, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Aleris Obesity

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Super Obesity, i.e. a BMI above 50, is difficult to treat. Normal gastric bypass surgery is not always enough for proper weight control. Bypassing a longer segment of the gut may be more beneficial. Which part to bypass is not clear. The investigators want to compare the effects between preventing a 60 cm proximal (oral) portion of the jejunum from food contact with the effects when preventing a 200 cm part of the jejunum from contact with bile and pancreatic juice. Endpoints are quality of life, gastrointestinal function, and weight development.
Detailed Description
Two variations of gastric bypass are compared: Method 1 (test method):A 200 cm BP-limb (distance Treitz to EA) + 150 cm common channel (EA to ileocecal valve) + Roux-Y-limb variable Method 2 (standard method): A 60 cm BP limb + 150 cm Roux-Y-limb + common channel variable. Patients are evaluated according to the principles of the Scandinavian Obesity surgery registry (SOReg) with the addition of two additional questionnaires. FU time is set at 5 years.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Morbid Obesity, Weight Loss
Keywords
gastric bypass, morbid obesity, gut function, weight loss

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomised study between long and standard biliopancreatic limb in gstric bypass surgery
Masking
InvestigatorOutcomes Assessor
Masking Description
Randomisation in the OR, (closed envelopes, blocks of six) no further info to ward or follow-up unit. No specific info as to randomisation outcome given to patients, all patients follow same protocol. Code number in operative charts.
Allocation
Randomized
Enrollment
140 (Actual)

8. Arms, Groups, and Interventions

Arm Title
standard length bp limb, long alimentary limb
Arm Type
Active Comparator
Arm Description
our normal way of doing a gastric bypass 60 cm BP limb
Arm Title
Long BP limb
Arm Type
Experimental
Arm Description
200 cm BP limb
Intervention Type
Procedure
Intervention Name(s)
gastric bypass
Intervention Description
two techniques of gastric bypass for studying the effects of making a long BP-limb
Primary Outcome Measure Information:
Title
body weight reduction
Description
absolute BW reduction, percentage of patients reaching BMI below 30,
Time Frame
5 years
Secondary Outcome Measure Information:
Title
gastrointestinal function
Description
SF-36, Op-9, GSRS and TFEQ are used in patient assessed variables
Time Frame
5 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: BMI 50-65 Age 18-55 Conservative attempts at weight reduction failed Exclusion Criteria: Inability to speak and understand the Swedish language Residence outside the county of Skåne Psychotic disease Inflammatory bowel disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jan L Hedenbro
Organizational Affiliation
Lunds Universitets Diabetescentrum
Official's Role
Principal Investigator
Facility Information:
Facility Name
Aleris Obesity Skåne
City
Lund
ZIP/Postal Code
SE 222 70
Country
Sweden

12. IPD Sharing Statement

Citations:
PubMed Identifier
32931641
Citation
Nergard BJ, Leifson BG, Gislason H, Hedenbro JL. Effect of different limb lengths on quality of life, eating patterns and gastrointestinal symptoms after Roux-en-Y gastric bypass in superobese patients: randomized study. BJS Open. 2020 Sep 15;4(6):1109-16. doi: 10.1002/bjs5.50334. Online ahead of print.
Results Reference
derived
PubMed Identifier
26143297
Citation
Nergard BJ, Lindqvist A, Gislason HG, Groop L, Ekelund M, Wierup N, Hedenbro JL. Mucosal glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide cell numbers in the super-obese human foregut after gastric bypass. Surg Obes Relat Dis. 2015 Nov-Dec;11(6):1237-46. doi: 10.1016/j.soard.2015.03.021. Epub 2015 Apr 2.
Results Reference
derived

Learn more about this trial

Effects of Long Biliopancreatic Limb vs. Long Alimentary Limb in Superobesity, a Randomized Study

We'll reach out to this number within 24 hrs